title: Identification of the minimum pharmacophore of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1D1.
abstract: We previously reported a unique peptide-peptoid hybrid, PPS1 that specifically recognizes lipid-phosphatidylserine (PS) and a few other negatively charged phospholipids, but not neutral phospholipids, on the cell membrane. The dimeric version of PPS1, i.e., PPS1D1 triggers strong cancer cell cytotoxicity and has been validated in lung cancer models both in vitro and in vivo. Given that PS and other negatively charged phospholipids are abundant in almost all tumor microenvironments, PPS1D1 is an attractive drug lead that can be developed into a globally applicable anti-cancer agent. Therefore, it is extremely important to identify the minimum pharmacophore of PPS1D1. In this study, we have synthesized alanine/sarcosine derivatives as well as truncated derivatives of PPS1D1. We performed ELISA-like competitive binding assay to evaluate the PS-recognition potential and standard MTS cell viability assay on HCC4017 lung cancer cells to validate the cell cytotoxicity effects of these derivatives. Our studies indicate that positively charged residues at the second and third positions, as well as four hydrophobic residues at the fifth through eighth positions, are imperative for the binding and activity of PPS1D1. Methionine at the first position was not essential, whereas the positively charged Nlys at the fourth position was minimally needed, as two derivatives that were synthesized replacing this residue were almost as active as PPS1D1.
authors.affiliation: Department of Pharmacological & Pharmaceutical Sciences, University of Houston, 3455 Cullen Blvd., Houston, TX 77204-5037, USA.
authors.forename: Jaspal
authors.initials: J
authors.lastname: Singh
authors.affiliation: Department of Pharmacological & Pharmaceutical Sciences, University of Houston, 3455 Cullen Blvd., Houston, TX 77204-5037, USA.
authors.forename: Satya Prakash
authors.initials: SP
authors.lastname: Shukla
authors.affiliation: Department of Pharmacological & Pharmaceutical Sciences, University of Houston, 3455 Cullen Blvd., Houston, TX 77204-5037, USA.
authors.forename: Tanvi J
authors.initials: TJ
authors.lastname: Desai
authors.affiliation: Department of Pharmacological & Pharmaceutical Sciences, University of Houston, 3455 Cullen Blvd., Houston, TX 77204-5037, USA; Department of Cancer Systems Imaging, MD Anderson Cancer Center, 1881 East Road, Houston, TX 77030-4009, USA. Electronic address: gomika@uh.edu.
authors.forename: D Gomika
authors.initials: DG
authors.lastname: Udugamasooriya
mesh_terms: D045744:Cell Line, Tumor; D019281:Dimerization; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D008055:Lipids / Q000737:chemistry*; D034444:Peptoids / Q000737:chemistry*; D010718:Phosphatidylserines / Q000737:chemistry*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
chemical_list: D008055:Lipids; D034444:Peptoids; D010718:Phosphatidylserines
keywords: Minimum pharmacophore; Peptoids; Sarcosine-scan; phosphatidylserine (PS)